Series B funding round for Repertoire Immune Medicines raising $190M in April 2021
Series B funding round for Repertoire Immune Medicines raising $190M in April 2021
| Investor | Firm Type |
|---|
| Partner |
|---|
| Venture Capital | — | |
| Government Office | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$215M
Top Valuation
-
Repertoire Immune Medicines raised $190M in a Series B round.
The round was announced on 04/01/21.
The round was led by Flagship Ventures.